Albemarle Future Growth
Future criteria checks 4/6
Albemarle is forecast to grow earnings and revenue by 67.4% and 9.1% per annum respectively. EPS is expected to grow by 68.7% per annum. Return on equity is forecast to be 4.3% in 3 years.
Key information
67.4%
Earnings growth rate
68.7%
EPS growth rate
Chemicals earnings growth | 46.3% |
Revenue growth rate | 9.1% |
Future return on equity | 4.3% |
Analyst coverage | Good |
Last updated | 19 Nov 2024 |
Recent future growth updates
Recent updates
Earnings and Revenue Growth Forecasts
Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
---|---|---|---|---|---|
12/31/2026 | 6,807 | 2,600 | 196 | 1,397 | 17 |
12/31/2025 | 5,851 | 813 | -117 | 1,016 | 26 |
12/31/2024 | 5,497 | -1,387 | -1,107 | 618 | 21 |
9/30/2024 | 6,502 | -1,967 | -1,411 | 603 | N/A |
6/30/2024 | 7,458 | -554 | -1,265 | 991 | N/A |
3/31/2024 | 8,398 | 326 | -1,611 | 702 | N/A |
12/31/2023 | 9,617 | 1,573 | -824 | 1,325 | N/A |
9/30/2023 | 9,882 | 3,324 | 465 | 2,376 | N/A |
6/30/2023 | 9,663 | 3,918 | 964 | 2,642 | N/A |
3/31/2023 | 8,773 | 3,675 | 977 | 2,423 | N/A |
12/31/2022 | 7,320 | 2,690 | 646 | 1,908 | N/A |
9/30/2022 | 5,593 | 1,554 | -308 | 809 | N/A |
6/30/2022 | 4,332 | 264 | -1,041 | 19 | N/A |
3/31/2022 | 3,626 | 281 | -613 | 392 | N/A |
12/31/2021 | 3,328 | 124 | -609 | 344 | N/A |
9/30/2021 | 3,313 | 212 | -54 | 828 | N/A |
6/30/2021 | 3,229 | 703 | 148 | 977 | N/A |
3/31/2021 | 3,219 | 364 | -14 | 802 | N/A |
12/31/2020 | 3,129 | 376 | -52 | 799 | N/A |
9/30/2020 | 3,242 | 382 | -29 | 835 | N/A |
6/30/2020 | 3,375 | 438 | -127 | 728 | N/A |
3/31/2020 | 3,496 | 507 | -31 | 820 | N/A |
12/31/2019 | 3,589 | 533 | -132 | 719 | N/A |
9/30/2019 | 3,519 | 572 | -322 | 515 | N/A |
6/30/2019 | 3,417 | 547 | -313 | 522 | N/A |
3/31/2019 | 3,385 | 695 | -305 | 480 | N/A |
12/31/2018 | 3,375 | 694 | -154 | 546 | N/A |
9/30/2018 | 3,311 | 346 | 4 | 606 | N/A |
6/30/2018 | 3,288 | 335 | N/A | 582 | N/A |
3/31/2018 | 3,172 | 135 | N/A | 343 | N/A |
12/31/2017 | 3,072 | 55 | N/A | 304 | N/A |
9/30/2017 | 2,911 | 315 | N/A | 356 | N/A |
6/30/2017 | 2,810 | 302 | N/A | 428 | N/A |
3/31/2017 | 2,742 | 282 | N/A | 645 | N/A |
12/31/2016 | 2,677 | 442 | N/A | 736 | N/A |
9/30/2016 | 2,703 | 560 | N/A | 498 | N/A |
6/30/2016 | 2,742 | 510 | N/A | 480 | N/A |
3/31/2016 | 2,791 | 468 | N/A | 488 | N/A |
12/31/2015 | 2,826 | 302 | N/A | 361 | N/A |
9/30/2015 | 2,702 | 124 | N/A | 379 | N/A |
6/30/2015 | 2,652 | 149 | N/A | 331 | N/A |
3/31/2015 | 2,538 | 190 | N/A | 389 | N/A |
12/31/2014 | 2,446 | 203 | N/A | 493 | N/A |
9/30/2014 | 2,487 | 377 | N/A | 546 | N/A |
6/30/2014 | 2,435 | 388 | N/A | 549 | N/A |
3/31/2014 | 2,408 | 385 | N/A | 483 | N/A |
12/31/2013 | 2,394 | 409 | N/A | 433 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: A1LB34 is forecast to become profitable over the next 3 years, which is considered faster growth than the savings rate (10.4%).
Earnings vs Market: A1LB34 is forecast to become profitable over the next 3 years, which is considered above average market growth.
High Growth Earnings: A1LB34 is expected to become profitable in the next 3 years.
Revenue vs Market: A1LB34's revenue (9.1% per year) is forecast to grow faster than the BR market (7.4% per year).
High Growth Revenue: A1LB34's revenue (9.1% per year) is forecast to grow slower than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: A1LB34's Return on Equity is forecast to be low in 3 years time (4.3%).